| Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status M Nakhjavani, M Imani, M Larry, A Aghajani-Nargesi, A Morteza, ... Journal of Diabetes & Metabolic Disorders 13, 1-6, 2014 | 40 | 2014 |
| Iran pituitary tumor registry: description of the program and initial results ME Khamseh, MRM Tehrani, Z Mousavi, M Malek, M Imani, NH Tehrani, ... Archives of Iranian Medicine 20 (12), 746-751, 2017 | 19 | 2017 |
| Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas AB Barooni, M Ghorbani, V Salimi, A Alimohammadi, ME Khamseh, ... Lipids in Health and Disease 18, 1-11, 2019 | 11 | 2019 |
| Prostaglandin F2 alpha plasma concentration predicts glycemic control and oxidation status in patients with type 2 diabetes mellitus M Nakhjavani, Z Ghazizadeh, AA Nargesi, A Mokhtari, F Asgarani, ... Clin Lab 60 (12), 2073-2080, 2014 | 11 | 2014 |
| Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas FI Shirian, M Ghorbani, ME Khamseh, M Imani, M Panahi, ... BMC Endocrine Disorders 21, 1-12, 2021 | 7 | 2021 |
| Comparison of cabergoline versus raloxifene add-on therapy to long-acting somatostatin analogue in patients with inadequately controlled acromegaly: a randomized open label … M Imani, ME Khamseh, P Asadi, M Ghorbani, H Akbari, F Alaei-Shahmiri, ... Endocrine Practice 24 (6), 542-547, 2018 | 6 | 2018 |
| Evaluation of the expression of necroptosis pathway mediators and its association with tumor characteristics in functional and non-functional pituitary adenomas ME Khamseh, A Sheikhi, Z Shahsavari, M Ghorbani, H Akbari, M Imani, ... BMC Endocrine Disorders 22 (1), 1, 2022 | 5 | 2022 |
| The lost correlation between heat shock protein 70 (HSPA1A) and plasminogen activator inhibitor-1 in patients with type 2 diabetes and albuminuria AA Nargesi, M Shalchi, RA Nargesi, N Sadeghpour, M Zarifkar, ... Cell Stress and Chaperones 21 (2), 361-365, 2016 | 5 | 2016 |
| Gender difference in plasminogen activator inhibitor-1 activity in patients with type 2 diabetes with and without albuminuria, a matched case-control study M Imani, S Rabizadeh, M Nakhjavani, P Hashemi, S Pezeshki, R Hizomi, ... Functional Foods in Health and Disease 9 (7), 484-493, 2019 | 1 | 2019 |
| Melanoma and Associated MicroRNAs N Afrang, M Imani, M Honardoost Journal of Skin and Stem Cell 3 (4), 2016 | 1 | 2016 |
| The effect of treatment duration on metabolic parameters in patients with prolactinoma: A prospective longitudinal study M Imani, R Abbasi, F Golgiri, A Khajavi, H Akbari Journal of Diabetes and Endocrine Practice 4 (01), 30-34, 2021 | | 2021 |
| Melanoma and Associated MicroRNAs M Imani, N Afrang Brieflands, 2016 | | 2016 |
Alireza EsteghamatiTehran University of Medical SciencesVerified email at tums.ac.ir
